ALEC
NASDAQ · Biotechnology
Alector Inc
$2.63
+0.10 (+3.95%)
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+709.9% upside
Low Target
$14.71
Average Target
$21.30
High Target
$34.17
Current Price
$2.63
Current
$2.63
$2.63
Target
$21.30
$21.30
$14.71
$21.30 avg
$34.17
Scenario Analysis
Bear Case
$14.71
459.3%
Low target
Base Case
$21.30
+709.9%
Avg target
Bull Case
$34.17
+1,199.2%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$2.76
-4.7% from high
52-Week Low
$1.09
+141.3% from low
Target vs 52W High
$21.30
+671.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |